Skip to content

Category Archives: Initial Public Offering IPO

Move a device idea from the research phase to the market > Massachusetts medical device industry > Industry-specific support > Innovation Index of the Massachusetts Economy > Massachusetts Biomedical Initiatives > Dow Jones VentureSource > Massachusetts Technology Collaborative’s John Adams Innovation Institute > Worcester business incubators

Wednesday, February 13, 2008

Is Massachusetts a Medtech hub that benefits from industry that has developed there close to all the universities? Is the infrastructure for both the creation of device ideas and the development of device ideas unique to the state of Massachusetts? Why can medical device companies gain a foothold in Massachusetts that they cannot gain elsewhere?

IIP […]

Filed in Massachusetts medical device industry, BioVentures Investors, Medical device bill, Crescent Innovations Inc, Polymer injected into the body to reduce inflammation, TMJ pain treatment, AcroMIS LLC, Industry-specific support, Mount Auburn Hospital, McLean Hospital, Schepens Eye Research Institute, Spaulding Rehabilitation Hospital, Medical device business incubators, VA Boston, Entegrion's Stasilon, Wound care, Move a device idea from the research phase to the marke, Corporate partnerships, Innovation Index of the Massachusetts Economy, Massachusetts Biomedical Initiatives, Worcester business incubators, John Adams Innovation Institute, Angel groups, Detect the nuclei of atoms, Plastics injection molding, Nypro Inc, HydroCision Inc, Water-jet tools for surgeons, Nuclear resonance technology, SIV Technologies Inc, Massachusetts General Hospital, Massachusetts Eye and Ear Infirmary, Innovative technology, Start-up companies, Endoscopy Endoscopic, Boston Scientific, Venture Capital Financing, Initial Public Offering IPO, Food and Drug Administration FDA, Innovative products, Flexible endoscope, Laparoscopy Laparoscopic, Disclosing new technology and innovations, Medical Universities Research Institutes Med Societies, New product development, Endovascular stent graft, Entrepreneurs and investors, Medical Device Company, Forsyth Institute, Dana-Farber Cancer Institute, Harvard Pilgrim Health Care, Joslin Diabetes Center, Immune Disease Institute, Judge Baker Children's Center, Children's Hospital Boston, Cambridge Health Alliance, Drug eluting stents, Investigational device, Boston University Medical Center, US Healthcare is the largest industry in the United Sta, Brigham and Women's Hospital, Harvard Medical School, Medical Device Development | Comments (0)

ConforMIS receives EU approval for knee surgery technology > iUni Implant resurface portions on the knee due to arthritic damage > iJig cutting and placement tool is designed to limit the number of instruments needed > European market clearance for a knee implant and related surgical instrument

Wednesday, January 23, 2008

Is the fundamental challenge in a complex 3-D structure like the knee that surgeons must cut bone to fit the patient to the implant? Does ConforMIS use data from MRIs or CT scans taken before surgery to generate a 3-D model of a patient’s knee and design an implant to conform exactly to the area […]

Filed in Design implant to conform exactly, Surgeons cut bone to fit the patient, Data from MRIs or CT scans taken before surgery, No implant inventory for the company, Knee implant and related surgical instrument, Shaped for each patient, iJig cutting and placement tool, iUni, Minimally invasive knee replacement, Spin-off of Imaging Therapeutics, Minimally invasive approach, Minimally invasive surgery techniques, Less-invasive, Initial Public Offering IPO, Development Stage Medical Device Company, ConforMIS, Medical Device Company, Entrepreneurs and investors, Minimally Invasive Surgery MIS | Comments (0)

Power Medical Interventions Inc PMI Receives FDA 510k Marketing Clearance for iDrive Intelligent Surgical

Tuesday, January 8, 2008

Is the iDrive a step towards computer-assisted, power-actuated endomechanical instruments for use in minimally invasive surgery? Are Robotic Articulating Endoscopic Linear Cutter making the conventional linear staplers obsolete? Will there be more Intelligent Surgical Instruments developed for use in the emerging field of Natural Orifice Translumenal Endoscopic Surgery NOTES?

IIP > Read on here…
…the U.S. Food […]

Filed in Circular staplers, SurgASSIST, Gastrointestinal, Right-angle linear cutter, Linear cutter, Michael Whitman, Digital Loading Units, Gynecological, General abdominal, Improved access to anatomical sites, Superior compressive force, Greater precision and consistency, Enhanced ease of use, Creation of anastomoses, Vascular surgical procedures, Thoracic surgical procedures, Power-actuated endomechanical instruments, Computer-assisted, Stapler for flexible endoscopes, FDA regulators, Hybrid procedures combining endoscopy and laparoscopy, Food and Drug Administration FDA, Initial applications of NOTES, Hybrid Endoluminal Endolumenal Laparoscopic MIS, NOTES, Hybrid and endoluminal treatment options, Clinical practice, Power Medical Interventions Inc PMI, iDrive, i60 Articulating Endoscopic Linear Cutter, Medical Device Company, Entrepreneurs and investors, Initial Public Offering IPO, Clinical and physiologic patterns, Medical Device Development | Comments (0)

EnteroMedics Inc. Announces Initial Public Offering IPO > Development Stage Medical Device Company > Neuroblocking Technology > VBLOC™ Vagal Blocking Therapy With Maestro System For Treatment Of Obesity

Saturday, November 17, 2007

Will neuroblocking technology and VBLOC™ vagal blocking therapy be successful in treating obesity? Why was the planned initial public offering at 5 million shares for an estimated price of $14 to $16 reduced to $8 per share? Do investors appreciate EnteroMedics Inc, a development stage medical device company as a viable option to treat obesity?

[…]

Filed in Neuroblocking Technology, Development Stage Medical Device Company, Vagal Blocking Therapy, Maestro System, Obesity, Treatment Of Obesity, Initial Public Offering IPO, EnteroMedics Inc, GERD, FDA regulators, EndoRefix, Diabetes, Body mass index, Disclosing new technology and innovations | Comments (0)